Sucralfate
NDC Package 29033-003-01
Package Information
Sucralfate is a medication used to treat and prevent ulcers in the intestines. Marketed by Nostrum Laboratories, Inc., this product is identified by NDC 29033-003 and is authorized under FDA application ANDA074415.
Identification & Billing
- RxCUI: 314234 - sucralfate 1 GM Oral Tablet
- RxCUI: 314234 - sucralfate 1000 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 29033 - Nostrum Laboratories, Inc.
- 29033-003 - Sucralfate
- 29033-003-01 - 100 TABLET in 1 BOTTLE, PLASTIC
- 29033-003 - Sucralfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (29033-003). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 29033-003-01 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Sucralfate, labeled by Nostrum Laboratories, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nostrum Laboratories, Inc. on February 17, 2020. The current certification is valid through December 31, 2025.
What are the primary indications for this medication?
This medication is used to treat and prevent ulcers in the intestines. Sucralfate forms a coating over ulcers, protecting the area from further injury. This helps ulcers heal more quickly.
How is this Nostrum Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 29033000301. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.